VistaGen Therapeutics, Inc. (14)

Browse by Contract Category

Contracts

Indemnification Agreement, dated July 21, 2021, by and between VistaGen Therapeutics, Inc. and Margaret M. FitzPatrick (Filed With SEC on July 22, 2021)
Open Market Sale AgreementSM, dated May 14, 2021, by and between VistaGen Therapeutics, Inc. and Jefferies LLC (Filed With SEC on May 14, 2021)
Underwriting Agreement, dated December 18, 2020, by and among VistaGen Therapeutics, Inc., Jefferies LLC and William Blair & Company, L.L.C (Filed With SEC on December 22, 2020)
Indemnification Agreement, dated July 6, 2021, by and between VistaGen Therapeutics, Inc. and Mary L. Rotunno J.D (Filed With SEC on July 8, 2021)
License and Collaboration Agreement, by and between VistaGen Therapeutics, Inc. and EverInsight Therapeutics Inc., dated June 24, 2020 (Filed With SEC on August 13, 2020)
Underwriting Agreement, dated August 2, 2020, by and between VistaGen Therapeutics, Inc. and Maxim Group LLC (Filed With SEC on August 6, 2020)
License and Collaboration Agreement, by and between VistaGen Therapeutics, Inc. and EverInsight Therapeutics Inc., dated June 24, 2020 (Filed With SEC on June 26, 2020)
Form of Warrant (Filed With SEC on January 27, 2020)
Form of Securities Purchase Agreement, dated January 24, 2020, between the Company and each purchaser named in the signature pages thereto (Filed With SEC on January 27, 2020)
Form of Subscription Agreement for Fall 2019 Private Placement (Filed With SEC on November 7, 2019)
Indemnification Agreement, dated November 10, 2016, by and between VistaGen Therapeutics, Inc. and Mark A. McPartland (Filed With SEC on June 25, 2019)
Master Services Agreement, dated July 11, 2017, by and between VistaGen Therapeutics, Inc. and Cato Research Ltd (Filed With SEC on June 25, 2019)
Underwriting Agreement, dated February 26, 2019, by and between VistaGen Therapeutics, Inc. and William Blair & Company, L.L.C (Filed With SEC on March 4, 2019)
Indemnification Agreement, dated January 10, 2019, by and between VistaGen Therapeutics, Inc. and Ann Cunningham (Filed With SEC on January 15, 2019)